

Is Ryaltris in shortage in 2026? Get the latest update on availability, pricing, and what to do if you can't find your allergy nasal spray.
If you've had trouble filling your Ryaltris prescription recently, you're probably wondering: is there a Ryaltris shortage? The answer depends on what we mean by "shortage" — and the situation is more nuanced than a simple yes or no.
In this update, we'll break down the current state of Ryaltris availability in 2026, explain why you might be having trouble finding it, and give you practical steps to get your prescription filled.
As of early 2026, Ryaltris is not listed on the FDA drug shortage database or the American Society of Health-System Pharmacists (ASHP) shortage list. This means there is no official, widespread manufacturing shortage of Ryaltris.
However, that doesn't mean you won't have trouble finding it at your local pharmacy. Many patients report that individual pharmacies are out of stock, particularly during spring and fall allergy seasons. This is a supply-demand mismatch at the pharmacy level, not a national shortage — but the result for patients is the same: you can't get your medication when you need it.
Several factors contribute to Ryaltris availability problems, even without an official shortage:
Ryaltris (Olopatadine/Mometasone) is a brand-name-only medication. There is no generic version as of 2026. When only one manufacturer (Hikma Specialty USA) produces a drug, the supply chain has no redundancy. Any production hiccup or distribution delay can ripple through to pharmacy shelves. For a deeper look at this issue, read our post on why Ryaltris is so hard to find.
Ryaltris is specifically indicated for seasonal allergic rhinitis. When pollen counts spike in spring (March through May) and again in fall (September through November), demand for Ryaltris surges. Pharmacies that carry just a few bottles can sell out quickly, and wholesaler restock times can't always keep up.
Many insurance plans require patients to try less expensive options — like OTC Flonase or generic Mometasone — before approving Ryaltris. This means fewer pharmacies stock it in large quantities because they fill fewer prescriptions for it. When a patient finally does get insurance approval, the pharmacy may not have it on hand.
Large chain pharmacies use automated inventory systems that prioritize high-volume generics. A brand-name, specialty-priced nasal spray like Ryaltris may not meet the volume thresholds to be automatically restocked. This is especially true at pharmacies in areas with lower allergy prescription volumes.
Cost is a major factor in the Ryaltris availability equation. Here's the current pricing landscape:
For a complete breakdown of savings options, read our guide on how to save money on Ryaltris in 2026.
While no generic Ryaltris is available yet, the allergy medication landscape continues to evolve:
For a full rundown of your options, check out our post on alternatives to Ryaltris.
If you need Ryaltris today, here's your action plan:
For more tips, read our detailed guide on how to find Ryaltris in stock near you.
While Ryaltris is not in a formal nationwide shortage in 2026, real-world availability can be inconsistent — especially during peak allergy seasons and at large chain pharmacies. The combination of being a brand-name-only product, seasonal demand patterns, and insurance barriers creates a perfect storm of availability challenges.
The good news: with the right tools and a little planning, you can find and afford Ryaltris. Start with Medfinder to check stock near you, use the manufacturer savings card to save money, and talk to your doctor about backup options in case Ryaltris isn't available when you need it.
We'll continue to update this page as the availability situation evolves. Bookmark it and check back for the latest information.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.